RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,712,314 | +57.2% | 618,820 | +35.4% | 0.00% | – |
| Q2 2023 | $2,997,428 | +2020.6% | 456,925 | +1833.1% | 0.00% | – |
| Q1 2023 | $141,349 | +149.6% | 23,637 | -2.7% | 0.00% | – |
| Q4 2022 | $56,626 | -29.2% | 24,303 | +2.1% | 0.00% | – |
| Q3 2022 | $80,000 | +31.1% | 23,803 | +3.4% | 0.00% | – |
| Q2 2022 | $61,000 | -93.5% | 23,012 | -92.7% | 0.00% | – |
| Q1 2022 | $932,000 | -65.6% | 317,027 | +0.0% | 0.00% | – |
| Q4 2021 | $2,709,000 | +23.6% | 316,875 | +7.7% | 0.00% | – |
| Q3 2021 | $2,191,000 | -19.0% | 294,281 | +1.5% | 0.00% | – |
| Q2 2021 | $2,704,000 | – | 289,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |